Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon‐based therapy in chronic hepatitis C

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|6|1075-1084

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.6, 2015-06, pp. : 1075-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E115-E121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Effects of Interferon-Based Therapy for Chronic Hepatitis C

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

Interleukin‐ 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 9, 2015-09 ,pp. : 765-771

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon Therapy of Chronic Hepatitis B

By  

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 163-170

Karger

Access to resources Recommend Favorite

Artificial Neural Network Model Is Superior to Logistic Regression Model in Predicting Treatment Outcomes of Interferon-Based Combination Therapy in Patients with Chronic Hepatitis C

By  

Intervirology, Vol. 51, Iss. 1, 2008-02 ,pp. : 14-20

Karger

Access to resources Recommend Favorite